My Quote Request
6505-00-889-9034
20 Products
NDC00904-7927-80
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008899034
NSN
6505-00-889-9034
NDC00904-7927-80
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008899034
NSN
6505-00-889-9034
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS BISACODYL ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISACODYL TABLETS USP 5MG FILM ENTERIC 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00054-4098-31
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008899034
NSN
6505-00-889-9034
NDC00054-4098-31
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008899034
NSN
6505-00-889-9034
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS BISACODYL ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISACODYL TABLETS USP 5MG FILM ENTERIC 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00182-5034-10
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008899034
NSN
6505-00-889-9034
NDC00182-5034-10
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008899034
NSN
6505-00-889-9034
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS BISACODYL ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISACODYL TABLETS USP 5MG FILM ENTERIC 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00536-3381-10
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008899034
NSN
6505-00-889-9034
NDC00536-3381-10
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008899034
NSN
6505-00-889-9034
MFG
CARDINAL HEALTH 200 LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS BISACODYL ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISACODYL TABLETS USP 5MG FILM ENTERIC 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
22-214-43
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505008901110
NSN
6505-00-890-1110
22-214-43
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505008901110
NSN
6505-00-890-1110
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS PHENYTOIN PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: PALATABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYTOIN ORAL SUSP USP 125 MG PER 5 ML 1/2 PT (237 ML)
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES OR 237.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD-PROOF SAFETY CLOSURE
Related Searches:
DILANTIN
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505008901110
NSN
6505-00-890-1110
DILANTIN
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505008901110
NSN
6505-00-890-1110
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS PHENYTOIN PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: PALATABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYTOIN ORAL SUSP USP 125 MG PER 5 ML 1/2 PT (237 ML)
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES OR 237.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD-PROOF SAFETY CLOSURE
Related Searches:
DILANTIN-125
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505008901110
NSN
6505-00-890-1110
DILANTIN-125
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505008901110
NSN
6505-00-890-1110
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS PHENYTOIN PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: PALATABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYTOIN ORAL SUSP USP 125 MG PER 5 ML 1/2 PT (237 ML)
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES OR 237.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD-PROOF SAFETY CLOSURE
Related Searches:
NDC00071-2214-20
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505008901110
NSN
6505-00-890-1110
NDC00071-2214-20
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505008901110
NSN
6505-00-890-1110
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS PHENYTOIN PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: PALATABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYTOIN ORAL SUSP USP 125 MG PER 5 ML 1/2 PT (237 ML)
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES OR 237.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD-PROOF SAFETY CLOSURE
Related Searches:
13960
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008901189
NSN
6505-00-890-1189
13960
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008901189
NSN
6505-00-890-1189
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS BISACODYL ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-0534-01
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008901189
NSN
6505-00-890-1189
NDC00182-0534-01
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008901189
NSN
6505-00-890-1189
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS BISACODYL ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00597-0012-01
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008901189
NSN
6505-00-890-1189
NDC00597-0012-01
BISACODYL DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505008901189
NSN
6505-00-890-1189
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS BISACODYL ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DIBENZYLINE
PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505008901193
NSN
6505-00-890-1193
DIBENZYLINE
PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505008901193
NSN
6505-00-890-1193
MFG
WELLSPRING PHARMACEUTICAL CORPORATION
Description
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.001 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.01 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PHENOXYBENZAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC65197-0001-01
PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505008901193
NSN
6505-00-890-1193
NDC65197-0001-01
PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505008901193
NSN
6505-00-890-1193
MFG
WELLSPRING PHARMACEUTICAL CORPORATION
Description
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.001 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.01 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PHENOXYBENZAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
639
BETAZOLE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505008901200
NSN
6505-00-890-1200
639
BETAZOLE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505008901200
NSN
6505-00-890-1200
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS BETAZOLE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
6505-00-C99-0107
BETAZOLE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505008901200
NSN
6505-00-890-1200
6505-00-C99-0107
BETAZOLE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505008901200
NSN
6505-00-890-1200
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS BETAZOLE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
HISTALOG
BETAZOLE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505008901200
NSN
6505-00-890-1200
HISTALOG
BETAZOLE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505008901200
NSN
6505-00-890-1200
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS BETAZOLE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00002-1439-16
BETAZOLE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505008901200
NSN
6505-00-890-1200
NDC00002-1439-16
BETAZOLE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505008901200
NSN
6505-00-890-1200
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS BETAZOLE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
ASA26
ASPIRIN SUPPOSITORIES,USP
NSN, MFG P/N
6505008901217
NSN
6505-00-890-1217
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE INGREDIENT AND STRENGTH: 300.000 ASPIRIN MILLIGRAMS
MEDICAMENT BASE TYPE: COCOA BUTTER
PRIMARY CONTAINER TYPE: PACKAGE
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 6 SUPPOSITORIES PER PACKAGE
Related Searches:
MYCOSTATIN
NYSTATIN TOPICAL POWDER,USP
NSN, MFG P/N
6505008901218
NSN
6505-00-890-1218
MYCOSTATIN
NYSTATIN TOPICAL POWDER,USP
NSN, MFG P/N
6505008901218
NSN
6505-00-890-1218
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100000.000 UNITS NYSTATIN PER GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NYSTATIN TOPICAL POWDER USP 100000 UNITS GM 15GM PLASTIC BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
Related Searches:
MYCOSTATIN POWDER
NYSTATIN TOPICAL POWDER,USP
NSN, MFG P/N
6505008901218
NSN
6505-00-890-1218
MYCOSTATIN POWDER
NYSTATIN TOPICAL POWDER,USP
NSN, MFG P/N
6505008901218
NSN
6505-00-890-1218
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100000.000 UNITS NYSTATIN PER GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NYSTATIN TOPICAL POWDER USP 100000 UNITS GM 15GM PLASTIC BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE